Impact News +++ Energy Fuels Aktie: Achtung, Aufholpotenzial! (Aktiencheck) +++ ENERGY FUELS Aktie -3,11%

CANNARA BIOTECH Aktie

>CANNARA BIOTECH Performance

1 Woche: 0%

1 Monat: -7,1%

3 Monate: -10,6%

6 Monate: +48,3%

1 Jahr: +58,9%

laufendes Jahr: +66,3%

>CANNARA BIOTECH Aktie

Name:

CANNARA BIOTECH INC.

Land:

Kanada

Sektor:

Gesundheit

ISIN/ Wkn:

CA13765U2002 / A3D495

Symbol/ Ticker:

8CB0 (Frankfurt)

Kürzel:

FRA:8CB0, ETR:8CB0, 8CB0:GR

Index:

Webseite:

https://www.cannara.ca/

Marktkapitalisierung:

71.3 Mio. EUR

Umsatz:

81.45 Mio. EUR

EBITDA:

19.3 Mio. EUR

Gewinn je Aktie:

0.078 EUR

Schulden:

42.3 Mio. EUR

Liquide Mittel:

4.38 Mio. EUR

Umsatz-/ Gewinnwachstum:

34.6% / -

KGV/ KGV lG:

8.06 / -

KUV/ KBV/ PEG:

1.1 / 1.09 / -

Gewinnm./ Eigenkapitalr.:

14.24% / 15.44%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

CANNARA BIOTECH, CANNARA BIO

Letzte Datenerhebung:

05.07.25

>CANNARA BIO Eigentümer

Aktien: 91.43 Mio. St.

f.h. Aktien: 44.71 Mio. St.

Insider Eigner: 49.17%

Instit. Eigner: 0.13%

Leerverk. Aktien: -

>CANNARA BIO Peer Group

AVRICORE

CARERX

CORE ONE LABS

GEMINA LABS

HEMOSTEMIX

IZOTROPIC

KDA GROUP

MTL CANNABIS

UNIDOC HEALTH

XBIOTECH

>CANNARA BIOTECH Chart & Kurs - Stuttgart

>CANNARA BIOTECH News

19.06.25 - 14:03	Cannara Biotech to Host Investor Webcast on June 25th, 2025 (GlobeNewswire EN)
	Cannara Biotech (TSXV: LOVE) to host investor webcast on June 25 to discuss growth, operations, and strategy. Register now to join the live Q&A session....

18.06.25 - 14:03	Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year (GlobeNewswire EN)
	Cannara Biotech wins 2025 Brand of the Year at Grow Up Awards, lowers debt cost through interest rate cut and debenture repayment, reinforcing financials...

28.04.25 - 12:24	Cannara Biotech reports Q1 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

16.04.25 - 13:03	Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025 (GlobeNewswire EN)
	Cannara Biotech to release Q2 2025 results on April 28. Webcast with CFO Nicholas Sosiak set for April 29 at 11AM ET....

24.03.25 - 13:33	Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors (GlobeNewswire EN)
	Cannara Biotech appoints Justin Cohen to its Board of Directors, enhancing brand strategy with his extensive marketing and digital transformation expertise...

06.03.25 - 14:03	Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025 (GlobeNewswire EN)
	Cannara Biotech will present at the Ventum Canadian Cannabis Conference on March 12th, 2025, showcasing its financial success, market growth, and cost adv....

27.01.25 - 16:57	Cannara Biotech GAAP EPS of C$0.03, revenue of C$25.1M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.12.24 - 15:33	Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024 (GlobeNewswire EN)
	Nicholas Sosiak, CFO, will conduct a presentation that will cover key financial and operational results for the fiscal year ended Auguust 31 2024....

25.11.24 - 15:33	Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada′s Cannabis Market (GlobeNewswire EN)
	Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production....

16.08.24 - 15:03	Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024 (GlobeNewswire EN)
	Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live QA...

23.07.24 - 20:24

Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure (Benzinga)

Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and nine-month periods ended May 31, 2024. Zohar Krivorot, president and CEO of Cannara, praised the company's "strong performance," during the period, with net revenues reaching CA$19.5 million ($14.2 million) during the quarter, representing a 22.6% year-over-year increase. "Historically, our sales growth has been driven by great customer loyalty and strong demand for our products, amplified by organic word-of-mouth promotion," Krivorot explained. "However, as indicated by our flat quarter-to-quarter results, this can only take us so far. To continue our expansion across the country, we have begun enhancing our sales force and infrastructure." read more...

23.07.24 - 19:42	Cannara Biotech GAAP EPS of C$0.02, revenue of C$19.5M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.07.24 - 14:33	Cannara Biotech Reports Q3 2024 Financial Results (GlobeNewswire EN)
	Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram